Using Bayes factors for testing hypotheses about intervention effectiveness in addictions research

Abstract Background and Aims It has been proposed that more use should be made of Bayes factors in hypothesis testing in addiction research. Bayes factors are the ratios of the likelihood of a specified hypothesis (e.g. an intervention effect within a given range) to another hypothesis (e.g. no effect). They are particularly important for differentiating lack of strong evidence for an effect and evidence for lack of an effect. This paper reviewed randomized trials reported in Addiction between January and June 2013 to assess how far Bayes factors might improve the interpretation of the data. Methods Seventy‐five effect sizes and their standard errors were extracted from 12 trials. Seventy‐three per cent (n = 55) of these were non‐significant (i.e. P > 0.05). For each non‐significant finding a Bayes factor was calculated using a population effect derived from previous research. In sensitivity analyses, a further two Bayes factors were calculated assuming clinically meaningful and plausible ranges around this population effect. Results Twenty per cent (n = 11) of the non‐significant Bayes factors were < ⅓ and 3.6% (n = 2) were > 3. The other 76.4% (n = 42) of Bayes factors were between ⅓ and 3. Of these, 26 were in the direction of there being an effect (Bayes factor > 1 and < 3); 12 tended to favour the hypothesis of no effect (Bayes factor < 1 and > ⅓); and for four there was no evidence either way (Bayes factor = 1). In sensitivity analyses, 13.3% of Bayes Factors were < ⅓ (n = 20), 62.7% (n = 94) were between ⅓ and 3 and 24.0% (n = 36) were > 3, showing good concordance with the main results. Conclusions Use of Bayes factors when analysing data from randomized trials of interventions in addiction research can provide important information that would lead to more precise conclusions than are obtained typically using currently prevailing methods.

[1]  M. Pavlicova,et al.  A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders. , 2013, Addiction.

[2]  Z. Diénès Understanding Psychology as a Science: An Introduction to Scientific and Statistical Inference , 2008 .

[3]  J. Rouder Optional stopping: No problem for Bayesians , 2014, Psychonomic bulletin & review.

[4]  E. Hanzal,et al.  The primary outcomes and power calculations in clinical RCTs in urogynecology - need for improvement? , 2015, Trials.

[5]  Dennis McCarty,et al.  Which elements of improvement collaboratives are most effective? A cluster-randomized trial. , 2013, Addiction.

[6]  E. Vittinghoff,et al.  Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial. , 2013, Addiction.

[7]  L. Sobell,et al.  Preventing alcohol-exposed pregnancies: a randomized controlled trial. , 2007, American journal of preventive medicine.

[8]  Richard D. Morey,et al.  BayesFactor version 0.9.9: An R package for computing Bayes factor for a variety of psychological research designs , 2014 .

[9]  N. Petry,et al.  Give them prizes, and they will come: contingency management for treatment of alcohol dependence. , 2000, Journal of consulting and clinical psychology.

[10]  P. Rucci,et al.  Aripiprazole and ropinirole treatment for cocaine dependence: evidence from a pilot study. , 2011, Current pharmaceutical design.

[11]  Mei Lan Fang,et al.  The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review , 2012, Addiction.

[12]  U. Bonnet,et al.  Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum. , 2014, Drug and alcohol dependence.

[13]  C. Gallistel,et al.  The Importance of Proving the Null , 2022 .

[14]  E. Wagenmakers A practical solution to the pervasive problems ofp values , 2007, Psychonomic bulletin & review.

[15]  R. Shelton,et al.  The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. , 2007, The Journal of clinical psychiatry.

[16]  James G. Murphy,et al.  Contingency management for alcohol use reduction: a pilot study using a transdermal alcohol sensor. , 2011, Drug and alcohol dependence.

[17]  Yih-Ing Hser,et al.  Predicting Long-Term Stable Recovery from Heroin Addiction , 2007, Journal of addictive diseases.

[18]  R. Richmond,et al.  A randomized controlled trial of a smoking cessation intervention conducted among prisoners , 2013, Addiction.

[19]  K. Cocks,et al.  Ongoing validation of health-related quality of life instruments , 2015, Trials.

[20]  J. Tiihonen,et al.  A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. , 2007, The American journal of psychiatry.

[21]  J. Krupnick Changing Network Support for Drinking: Network Support Project 2-Year Follow-Up , 2011 .

[22]  R P Mattick,et al.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. , 2009, The Cochrane database of systematic reviews.

[23]  D. D. Des Jarlais,et al.  Motivational interviewing to enhance nicotine patch treatment for smoking cessation among homeless smokers: a randomized controlled trial. , 2013, Addiction.

[24]  J. Sprenger The Objectivity of Subjective Bayesian Inference , 2015 .

[25]  K. Rendall-Mkosi,et al.  A randomized controlled trial of motivational interviewing to prevent risk for an alcohol-exposed pregnancy in the Western Cape, South Africa. , 2013, Addiction.

[26]  R. West Using Bayesian analysis for hypothesis testing in addiction science. , 2016, Addiction.

[27]  K. Delucchi,et al.  Knowledge and Attitudes About Methadone Maintenance Among Staff Working in a Therapeutic Community. , 2005, Journal of maintenance in the addictions.

[28]  N. Horton,et al.  Web-based alcohol intervention for Mäori university students: double-blind, multi-site randomized controlled trial , 2012, Addiction.

[29]  Jeffrey N. Rouder,et al.  Bayesian t tests for accepting and rejecting the null hypothesis , 2009, Psychonomic bulletin & review.

[30]  N. Horton,et al.  Randomized controlled trial of proactive web-based alcohol screening and brief intervention for university students. , 2009, Archives of internal medicine.

[31]  Jeffrey N. Rouder,et al.  Computation of Bayes Factors for Common Designs , 2015 .

[32]  I Campbell,et al.  Nicotine replacement therapy in smoking cessation. , 2003, Thorax.

[33]  Jennifer E. Hettema,et al.  Motivational interviewing for smoking cessation: a meta-analytic review. , 2010, Journal of consulting and clinical psychology.

[34]  J R Hughes,et al.  Antidepressants for smoking cessation. , 2007, The Cochrane database of systematic reviews.

[35]  R. Borland,et al.  Population-level effects of automated smoking cessation help programs: a randomized controlled trial. , 2013, Addiction.

[36]  N. Petry,et al.  A randomized study of cellphone technology to reinforce alcohol abstinence in the natural environment. , 2013, Addiction.

[37]  L. Stead,et al.  Antidepressants for smoking cessation. , 2014, The Cochrane database of systematic reviews.

[38]  J. Berger Statistical Decision Theory and Bayesian Analysis , 1988 .

[39]  M. Nettleman,et al.  Reducing alcohol-exposed pregnancy risk in college women: initial outcomes of a clinical trial of a motivational intervention. , 2005, Journal of substance abuse treatment.

[40]  S. Sutton,et al.  ESCAPE: a randomised controlled trial of computer-tailored smoking cessation advice in primary care. , 2013, Addiction.

[41]  N. Petry,et al.  Changing network support for drinking: network support project 2-year follow-up. , 2009, Journal of consulting and clinical psychology.

[42]  E. Vittinghoff,et al.  Mirtazapine to reduce methamphetamine use: a randomized controlled trial. , 2011, Archives of general psychiatry.

[43]  Zunyou Wu,et al.  An intervention targeting service providers and clients for methadone maintenance treatment in China: a cluster-randomized trial. , 2013, Addiction.

[44]  D. Linszen,et al.  Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia: a randomized controlled trial , 2011, Psychological Medicine.

[45]  M. Schervish P Values: What They are and What They are Not , 1996 .

[46]  R. Findling,et al.  The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial , 2009 .

[47]  Zoltan Dienes,et al.  Using Bayes to get the most out of non-significant results , 2014, Front. Psychol..

[48]  L. M. M.-T. Theory of Probability , 1929, Nature.

[49]  Ws Kaye,et al.  Book review: 'Understanding psychology as a science: an introduction to scientific and statistical inference' by Z. Dienes , 2009 .

[50]  L. Stead,et al.  Self-help interventions for smoking cessation. , 2005, The Cochrane database of systematic reviews.

[51]  Nick Freemantle,et al.  Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic? , 2001, BMJ : British Medical Journal.

[52]  Jeffrey N. Rouder,et al.  Default Bayes factors for ANOVA designs , 2012 .

[53]  A. Cnaan,et al.  Nicodermal patch adherence and its correlates. , 1999, Drug and alcohol dependence.

[54]  Richard D. Morey,et al.  Baysefactor: Computation of Bayes Factors for Common Designs , 2018 .

[55]  W. Maziak,et al.  Randomized trial of the effectiveness of combined behavioral/pharmacological smoking cessation treatment in Syrian primary care clinics. , 2013, Addiction.

[56]  Thom Baguley,et al.  Serious stats: a guide to advanced statistics for the behavioral sciences , 2012 .